SS Innovations International (SSII) Return on Capital Employed (2017 - 2026)
SS Innovations International's (SSII) quarterly Return on Capital Employed came in at 21.31% in Q1 2026, up 5407.0% year-on-year from 0.39% in Q1 2025, and up 31.91% quarter-over-quarter from 31.29% in Q4 2025.
SS Innovations International (SSII) Return on Capital Employed (2017 - 2026) Analysis & Trends
SS Innovations International has disclosed Return on Capital Employed across 10 years of filings, most recently posting 21.31% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 21.31%, up 5407.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 21.31% (up 5407.0% YoY), and the FY2025 annual result was 25.56%, up 9593.0% from the prior year.
- Return on Capital Employed came in at 21.31% for Q1 2026 at SS Innovations International, up from 31.29% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 449.96% in Q3 2022 to a low of 1549.82% in Q2 2022.
- The 5-year median for Return on Capital Employed is 94.91% (2023), against an average of 247.26%.
- Peak annual rise in Return on Capital Employed reached 163639 bps in 2022, while the deepest fall reached 170483 bps in 2022.
- SS Innovations International's Return on Capital Employed stood at 61.07% in 2022, then plunged by 255 bps to 94.91% in 2023, then plunged by 77 bps to 167.74% in 2024, then soared by 81 bps to 31.29% in 2025, then soared by 32 bps to 21.31% in 2026.
- The last three Return on Capital Employed figures came in at 21.31% (Q1 2026), 31.29% (Q4 2025), and 47.37% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | -21.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.31% |
| Dec 31, 2025 | -31.29% |
| Sep 30, 2025 | -47.37% |
| Jun 30, 2025 | -51.77% |
| Mar 31, 2025 | -75.37% |
| Dec 31, 2024 | -167.74% |
| Sep 30, 2024 | -155.46% |
| Jun 30, 2024 | -136.61% |
| Mar 31, 2024 | -142.85% |
| Dec 31, 2023 | -94.91% |
| Sep 30, 2023 | -76.25% |
| Jun 30, 2023 | -827.05% |
| Mar 31, 2023 | -280.50% |
| Dec 31, 2022 | 61.07% |
| Sep 30, 2022 | 449.96% |
| Jun 30, 2022 | -1,549.82% |
| Mar 31, 2022 | -1,056.09% |
| Dec 31, 2021 | -1,575.32% |
| Sep 30, 2021 | 152.17% |
| Jun 30, 2021 | 155.02% |